Panic Disorders Trends and Forecast
The future of the global panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Panic Disorders by Segment
The study includes a forecast for the global panic disorders by dosage, type, end use, and region.Panic Disorders Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:
- Tablets
- Injections
- Others
Panic Disorders Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Agoraphobia
- Social Anxiety Disorder
- Obsessive-Compulsive Disorder
- Bipolar Disorder
- Post-Traumatic Stress Disorder
- Specific Phobias
- Generalized Anxiety Disorder
- Major Depressive Disorder
Panic Disorders Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospitals
- Mental Healthcare Centres
- Asylums
- Others
Panic Disorders Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Panic Disorders Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies panic disorders companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the panic disorders companies profiled in this report include-- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Mylan
- Astrazeneca
- Abbott
- Baxter
- Bristol-Myers Squibb Company
- Eli Lilly And Company
- F. Hoffmann-La Roche
- Glaxosmithkline
Panic Disorders Market Insights
The publisher forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.Within this market, mental healthcare center will remain the largest segment as it delivers wide range of services, such as individual and group therapy, medication management, and crisis intervention.
North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.
Features of the Global Panic Disorders Market
- Market Size Estimates: Panic disorders market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Panic disorders market size by dosage, type, end use, and region in terms of value ($B).
- Regional Analysis: Panic disorders market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different dosage, types, end uses, and regions for the panic disorders market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the panic disorders market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for panic disorders market?Answer: The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the panic disorders market?
Answer: The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.
Q3. What are the major segments for panic disorders market?
Answer: The future of the panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets.
Q4. Who are the key panic disorders market companies?
Answer: Some of the key panic disorders companies are as follows:
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Mylan
- Astrazeneca
- Abbott
- Baxter
- Bristol-Myers Squibb Company
- Eli Lilly And Company
- F. Hoffmann-La Roche
- Glaxosmithkline
Answer: The publisher forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.
Q6. In panic disorders market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.
Q7. Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the panic disorders market by dosage (tablets, injections, and others), type (agoraphobia, social anxiety disorder, obsessive-compulsive disorder, bipolar disorder, post-traumatic stress disorder, specific phobias, generalized anxiety disorder, and major depressive disorder), end use (hospitals, mental healthcare centres, asylums, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Panic Disorders Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Mylan
- Astrazeneca
- Abbott
- Baxter
- Bristol-Myers Squibb Company
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
